SUMMARY
A female schizophrenic patient who developed Stevens Johnson syndrome following carbamazepine treatment is reported. This life threatening condition is discussed in context of other adverse effects of the drug, reportedly found to be higher in frequency in the psychiatric population.
Full Text
The Full Text of this article is available as a PDF (94.9 KB).
